1. Home
  2. KROS vs CSV Comparison

KROS vs CSV Comparison

Compare KROS & CSV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • CSV
  • Stock Information
  • Founded
  • KROS 2015
  • CSV 1991
  • Country
  • KROS United States
  • CSV United States
  • Employees
  • KROS N/A
  • CSV N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • CSV Other Consumer Services
  • Sector
  • KROS Health Care
  • CSV Consumer Discretionary
  • Exchange
  • KROS Nasdaq
  • CSV Nasdaq
  • Market Cap
  • KROS 558.9M
  • CSV 693.8M
  • IPO Year
  • KROS 2020
  • CSV 1996
  • Fundamental
  • Price
  • KROS $13.41
  • CSV $46.51
  • Analyst Decision
  • KROS Buy
  • CSV Strong Buy
  • Analyst Count
  • KROS 13
  • CSV 2
  • Target Price
  • KROS $20.63
  • CSV $50.50
  • AVG Volume (30 Days)
  • KROS 606.6K
  • CSV 94.5K
  • Earning Date
  • KROS 08-06-2025
  • CSV 07-30-2025
  • Dividend Yield
  • KROS N/A
  • CSV 0.97%
  • EPS Growth
  • KROS N/A
  • CSV 47.76
  • EPS
  • KROS 0.11
  • CSV 2.99
  • Revenue
  • KROS $214,713,000.00
  • CSV $407,774,000.00
  • Revenue This Year
  • KROS $5,006.76
  • CSV $1.96
  • Revenue Next Year
  • KROS N/A
  • CSV $2.93
  • P/E Ratio
  • KROS $122.43
  • CSV $15.49
  • Revenue Growth
  • KROS 91657.70
  • CSV 4.42
  • 52 Week Low
  • KROS $9.12
  • CSV $25.84
  • 52 Week High
  • KROS $72.37
  • CSV $46.47
  • Technical
  • Relative Strength Index (RSI)
  • KROS 42.34
  • CSV 68.50
  • Support Level
  • KROS $13.25
  • CSV $43.52
  • Resistance Level
  • KROS $13.99
  • CSV $46.47
  • Average True Range (ATR)
  • KROS 0.39
  • CSV 0.95
  • MACD
  • KROS -0.06
  • CSV 0.10
  • Stochastic Oscillator
  • KROS 22.49
  • CSV 100.00

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About CSV Carriage Services Inc.

Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise; and enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.

Share on Social Networks: